814 related articles for article (PubMed ID: 12152002)
21. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
23. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
27. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
29. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Iwasaki A
Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
[TBL] [Abstract][Full Text] [Related]
30. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
[TBL] [Abstract][Full Text] [Related]
31. Effects of the association of lansoprazole, clarithromycin and metronidazole for helicobacter Pylori eradication therapy, measured by the 13C Aminopyrine breath test.
Malfatti F; Giannini E; Emanuela T; Polegato S; Podestà E; Fumagalli A; Cotelessa T; Chiarbonello B; Bellotti M; Botta F; Milazzo S; Testa R
Med Sci Monit; 2005 Feb; 11(2):PI14-8. PubMed ID: 15668640
[TBL] [Abstract][Full Text] [Related]
32. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
33. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
35. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
Sullivan B; Coyle W; Nemec R; Dunteman T
Am J Gastroenterol; 2002 Oct; 97(10):2536-9. PubMed ID: 12385435
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
37. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
40. Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Uthaisaengsook W
J Med Assoc Thai; 2003 Jul; 86(7):599-602. PubMed ID: 12948252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]